Non-Small Cell Lung Cancer (NSCLC) Harboring EGFR Mutations (EGFR-m) and Breast Cancer (BC): A Retrospective Analysis

被引:0
|
作者
Moran, Teresa [1 ]
Quiroga, Vanesa [1 ]
Carcereny, Enric [1 ]
Cirauqui, Beatriz [1 ]
Margeli, Mireia [1 ]
Vila, Laia [1 ]
De Los, Maria [1 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Med Oncol, Badalona, Spain
关键词
EGFR mutations; Breast Cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MINI13.13
引用
收藏
页码:S310 / S311
页数:2
相关论文
共 50 条
  • [31] ANALYSIS OF THE EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER PATIENTS AFTER EGFR-TKIS TREATMENT
    Matsuo, Midori
    Nanae, Tomonaga
    Koichi, Izumikawa
    Hiroyuki, Yamaguchi
    Takaya, Ikeda
    Katsumi, Nakatomi
    Yoichi, Nakamura
    Kazuhiro, Tsukamoto
    Shigeru, Kohno
    RESPIROLOGY, 2010, 15 : 68 - 68
  • [32] Mutations of the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC).
    Sonobe, M
    Katakura, H
    Adachi, T
    Wada, H
    Tanaka, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 637S - 637S
  • [33] Serum carcinoembryonic antigen levels predicts the efficacy of EGFR-TKI in non-small cell lung cancer harboring EGFR mutations
    Zhang Yanwei
    Jin Bo
    Lou Yuqing
    Li Rong
    Zhang Xueyan
    Hu Song
    Han Baohui
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (01) : 254 - 258
  • [34] The significance of drug-tolerant cells by EGFR-TKIs in non-small cell lung cancer cells harboring with EGFR mutations
    Yamada, Tadaaki
    Yano, Seiji
    CANCER SCIENCE, 2021, 112 : 443 - 443
  • [35] Post-Progression Survival after EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Kogure, Yoshihito
    Saka, Hideo
    Oki, Masahide
    Saito, Toshiki I.
    Ahmed, Shimaa Nour Moursi
    Kitagawa, Chiyoe
    Imaizumi, Kazuyoshi
    PLOS ONE, 2015, 10 (08):
  • [36] EGFR mutation in non-small cell lung cancer(NSCLC) in South Croatia
    Mladinov, Suzana
    Skopljanac, Ivan
    Ivcevic, Veljka
    Kuret, Sendi
    Durdov, Meri Glavina
    Mise, Kornelija
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [37] Clinical efficacy of EGFR-TKIs in combination with chemotherapy in patients with advanced non-small cell lung cancer harboring EGFR mutations
    Zhang, Minghui
    Liu, Mingyang
    Wang, Yan
    JOURNAL OF THORACIC DISEASE, 2016, 8 (10) : E1293 - E1295
  • [38] CUSTOMIZING ERLOTINIB IN METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P) HARBORING EGFR MUTATIONS
    Sirera, R.
    Catot, S.
    Gonzalez-Larriba, J. L.
    Bover, I.
    Alonso, G.
    Valdivia, J.
    Ibeas, R.
    Lianes, P.
    Martinez del Prado, P.
    Rosell, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 90 - 90
  • [39] Impact of reflex testing for EGFR mutations in non-squamous non-small cell lung cancer (NSCLC).
    Cheema, Parneet Kaur
    Victor, Charles
    Dolley, Aastha
    Dziarmaga, Alison
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutations
    Ichihara, Eiki
    Hotta, Katsuyuki
    Takigawa, Nagio
    Kudo, Kenichiro
    Kato, Yuka
    Hondaa, Yoshihiro
    Hayakawa, Hiromi
    Minami, Daisuke
    Sato, Akiko
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    LUNG CANCER, 2013, 81 (03) : 435 - 439